Chronic Lymphocytic Leukemia in Elderly Patients: Own Experience
Journal Title: Lviv Clinical Bulletin - Year 2017, Vol 1, Issue 17
Abstract
Introduction. The annual incidence rate of chronic lymphocytic leukemia (CLL) in Europe is 14 per 100 000 population. The disease is more common in older patients. For many years treatment of CLL included singleagent chlorambucil or cyclophosphamide, later a combination of vincristine, cyclophosphamide, prednisolone (COP) alone or with addition of doxorubicin (CHOP) was used. In recent years, the arsenal of antileukemic agents has expanded significantly (fludarabine, cladribine, bendamustine, rituximab and others), a combination of these me dications provides a high percentage of complete remissions, but because of its immunosuppressive effect, this treatment cannot be used in all patients. In particular, in patients with comorbidities and older patients. Therefore a considerable attention has been recently paid to the management of the older patients with CLL. The purpose of the study was to analyze the timeliness of CLL diagnosis and management of elderly patients according to data of the Consultative Polyclinics of SI “Institute of Blood Pathology and Transfusion Medicine NAMS of Ukraine”. Results and discussion. 114 CLL patients aged from 61 to 86 were recruited in the study. More than 1/3 of patients were diagnosed with CLL in the late stages of the disease course (IIIIV Rai stage), which emphasizes the insufficient wariness for hematological disorders among family doctors and other medical specialists. Results of 220 years long observation show that the majority of the patients whose diagnosis was made on early stage (0I Rai stage) are well and do not require treatment. Indications for initiation of treatment in elderly patients are the same as in younger ones. Short cycles of treatment with chlorambucil in patients aged 6682 years result in partial remission with good patient condition and satisfactory quality of life with chlorambucil maintenance therapy dura tion from 24 to 132 months (at the time this publication was prepared). More aggressive therapy (bendamustine + rituximab and fludarabine + cyclophosphamide) in patients aged 6679 years is more efficient in terms of obtaining complete remission, but is more toxic and can be used in elderly patients who underwent comprehensive geriatric assessment with preserved renal function and absence of comorbidities. Conclusions. Chlorambucil alone or combined with prednisone should be considered for the firstline therapy of CLL in elderly patients. More aggressive therapies (FC, BR regimens) should be applied at disease progression as treatment of the second line.
Authors and Affiliations
О. Я. Виговська, Я. І. Виговська, О. О. Шалай, Л. М. Лукавецький, Ю. В. Войціцький, Л. В. Шевченко, В. А. Барілка, З. В. Масляк
Keywords
Related Articles
- EP ID EP254291
- DOI 10.25040/lkv2017.01.026
- Views 130
- Downloads 0
Quality of Life in Patients with Nonalcoholic Fatty Liver Disease in Combination with Essential Hypertension
Introduction. Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases where its frequency in the population varies within 3.0–40.0 %. Pathogenesis of nonalcoholic fatty liver disease has...
Алгоритм лечебной тактики у пациентов с опухолевой обструкцией внепеченочных желчных протоков
Введение. Проблема хирургического лечения больных с опухолями внепеченочных желчных протоков (ОЖП) является одной из важных и сложных в хирургии органов гепато-панкреато-дуоденальной зоны и вызывает все большую заинтерес...
Переломи лобового синуса: сучасна стратеґія діаґностично-лікувальної тактики
Вступ. Переломи лобового синуса, які виникають у 5,0-15,0 % випадків усіх травматичних пошкоджень кісток лицевого скелета, можуть варіювати від ізольованих переломів передньої стінки до множинних поєднаних пошкоджень син...
Коморбідність: сучасний погляд на проблему; клаcифікація (повідомлення друге)
Систематизація теоретичних і практичних знань про коморбідні захворювання, а отже, розв’язання цієї проблеми не переходить за межі наукових дискусій, з приводу чого й досі не існує погодженого розуміння її суті та уніфік...
Manifestations of Cellular Anomalies of Gingival Epithelium in Patients with Chronic Obstructive Pulmonary Diseases Combined with Coronary Heart Disease
Introduction. The priority of modern dentistry is a constant research of pathological changes in oral cavity occurring in patients with (COPD). Today under COPD we understand the growing abuse of lung function that cause...